Business, energy, technology, markets and global industry news from Business News Today

lung cancer screening

PharmaDeviceNews lung cancer screening
Representative image: AI-powered blood-based lung cancer screening is gaining momentum as DELFI Diagnostics secures New York approval for FirstLook Lung, expanding nationwide access to its laboratory-developed cancer detection test.
Medical Devices & Diagnostics

Why DELFI Diagnostics’ New York approval could shake up the lung cancer screening market

DELFI Diagnostics can now offer FirstLook Lung in all 50 states. Find out what this means for blood-based cancer screening.

Read More
Can eyonis LCS deliver real-world impact beyond regulatory milestones in lung cancer screening
Medical Devices & Diagnostics

What FDA clearance means for Median Technologies eyonis LCS in a crowded AI radiology market

Median Technologies advances eyonis LCS after FDA clearance. Discover what this means for AI lung cancer screening and European expansion.

Read More